Understanding the OV Monitor (CA 125) Blood Test: A Proactive Step in Women’s Health
For many women, navigating the complexities of gynaecological health can feel overwhelming. With a myriad of symptoms that can often be attributed to common, less serious conditions, it is easy to dismiss subtle changes in our bodies. However, taking a proactive approach to your health is crucial, and understanding the tools available to you is the first step. One such tool is the CA 125 blood test, a valuable marker that can provide important insights into your gynaecological wellbeing.
What is CA 125?
CA 125, or Cancer Antigen 125, is a protein found in the blood. While it is present in most women at low levels, elevated levels can sometimes indicate an underlying health issue. It is most commonly associated with ovarian cancer, as the cells of this type of cancer often produce higher amounts of the protein [1]. However, it is important to understand that a raised CA 125 level is not a definitive diagnosis of cancer.
Many benign (non-cancerous) conditions can also cause CA 125 levels to rise. These include endometriosis, fibroids, pelvic inflammatory disease, and even menstruation or pregnancy [2]. Therefore, the CA 125 test is typically used as one piece of a larger diagnostic puzzle, rather than a standalone answer.
How is the Test Used?
In the UK, the NHS often uses the CA 125 blood test as an initial investigation for women presenting with symptoms that could suggest ovarian cancer, such as persistent bloating, feeling full quickly, pelvic or abdominal pain, or needing to urinate more urgently or frequently [3]. If the test shows an elevated level, further investigations, such as an ultrasound scan, are usually recommended to determine the cause.
Beyond initial investigation, the CA 125 test is also a vital tool for monitoring women who have already been diagnosed with ovarian cancer. It helps healthcare professionals track the effectiveness of treatment and check for any signs of the cancer returning [4].
The Importance of Context
It is crucial to interpret CA 125 results within the context of your individual health profile. A “normal” level is generally considered to be under 35 units per millilitre (U/ml), but this can vary slightly depending on the laboratory [5]. Furthermore, some women with ovarian cancer may have normal CA 125 levels, particularly in the early stages of the disease.
This highlights the importance of not relying solely on the test, but rather using it in conjunction with a thorough medical history, symptom assessment, and other diagnostic tools.
Taking Control with the OV Monitor (CA 125) Blood Test
Understanding your body and being aware of any changes is empowering. The OV Monitor (CA 125) Blood Test can form part of a proactive approach to your gynaecological health. By providing a clear measurement of this important biomarker, it can help provide insight and may support informed conversations with a healthcare professional.
If you are experiencing persistent symptoms or simply want to gain a deeper understanding of your health, the OV Monitor (CA 125) Blood Test offers a convenient and reliable way to gather valuable information. Remember, this test does not replace the advice of a GP or specialist, but it can be a useful tool in your overall health strategy.
Explore this topic
Continue reading the related articles in this series:
- Early detection: Early Detection: Why Listening to Your Body Matters
- Personalised insights: Personalised Insights: Understanding Your Unique Biomarkers
- Empowerment: Peace of Mind: The Psychological Benefits of Knowing
Related test: OV Monitor (CA 125) Blood Test at Clinilabs.
References
[1] Target Ovarian Cancer. (n.d.). CA125 blood test. https://targetovariancancer.org.uk/about-ovarian-cancer/testing/ca125-blood-test
[2] Ovarian Cancer Action. (n.d.). CA125 Blood test for ovarian cancer. https://ovarian.org.uk/ovarian-cancer/ovarian-cancer-diagnosis/ca125/
[3] NHS. (n.d.). Tests and next steps - Ovarian cancer. https://www.nhs.uk/conditions/ovarian-cancer/tests-and-next-steps/
[4] Cancer Research UK. (n.d.). Tests for ovarian cancer. https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/getting-diagnosed/tests-ovarian-cancer
[5] National Institute for Health and Care Excellence (NICE). (2011). Ovarian cancer: recognition and initial management. https://www.nice.org.uk/guidance/cg122